María Cristina
Olague Micheltorena
German Cancer Research Center
Heidelberg, AlemaniaPublicacións en colaboración con investigadores/as de German Cancer Research Center (3)
2024
-
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1
EMBO molecular medicine, Vol. 16, Núm. 1, pp. 112-131
2016
-
Identification of IFN-γ-producing T cells as the main mediators of the side effects associated to mouse interleukin-15 sustained exposure
Oncotarget, Vol. 7, Núm. 31, pp. 49008-49026
2013
-
Safety and liver transduction efficacy of raav5-cohpbgd in nonhuman primates: A potential therapy for acute intermittent porphyria
Human Gene Therapy, Vol. 24, Núm. 12, pp. 1007-1017